Cited by 2,049Multiple Sclerosis Research StudiesViral-associated cancers and disordersCytomegalovirus and herpesvirus research

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Bjornevik, Kjetil, Cortese, Marianna, Healy, Brian C., Kuhle, Jens, Mina, Michael J., Leng, Yumei, Elledge, Stephen J., Niebuhr, David W., Scher, Ann I., Munger, Kassandra L., Ascherio, Alberto·2022·Science

DOI 10.1126/science.abj8222

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system of unknown etiology. We tested the hypothesis that MS is caused by Epstein-Barr virus (EBV) in a cohort comprising more than 10 million young adults on active duty in the US military, 955 of whom were diagnosed with MS during their period of service. Risk of MS increased 32-fold after infection with EBV but was not increased after infection with other viruses, including the similarly transmitted cytomegalovirus. Serum levels of neurofilament light chain, a biomarker of neuroaxonal degeneration, increased only after EBV seroconversion. These findings cannot be explained by any known risk factor for MS and suggest EBV as the leading cause of MS.

Integrity signals

Registry

Crossref · 10.1126/science.abj8222

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sensitivity analysis in observational research: Introducing the E-value
VanderWeele, T. J., & Ding, P. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2607 · Cited by 6,350
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Multiple sclerosis
Reich, D. S., Lucchinetti, C. F., & Calabresi, P. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1401483 · Cited by 2,491
The Immune Epitope Database (IEDB): 2018 update
Vita, R., Mahajan, S., Overton, J. A., Dhanda, S. K., Martini, S. R., Cantrell, J. R., Wheeler, D. K., Sette, A., & Peters, B. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1006 · Cited by 2,194
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Hauser, S. L., Bar-Or, A., Comi, G., Giovannoni, G., Hartung, H.-P., Hemmer, B., Lublin, F., Montalban, X., Rammohan, K. W., Selmaj, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1601277 · Cited by 2,021
Neurofilaments as biomarkers in neurological disorders
Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988
Negative Controls: A Tool for Detecting Confounding and Bias in Observational Studies
Lipsitch, M., Tchetgen Tchetgen, E., & Cohen, T. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181d61eeb · Cited by 1,583
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Olsson, T. P., Barcellos, L. F., & Alfredsson, L. S. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.187 · Cited by 1,263
Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis
Disanto, G., Barro, C., Benkert, P., Naegelin, Y., Schädelin, S., Giardiello, A., Zecca, C., Blennow, K., Zetterberg, H., Leppert, D., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24954 · Cited by 1,164
Epstein-Barr virus: exploiting the immune system
Thorley‐Lawson, D. A. (2001) · Nature reviews. Immunology · doi:10.1038/35095584 · Cited by 942

Flagged first, then by citations

Show all 51 references

1 of the 51 references couldn’t be matched to a known paper.

Sorted by citations

Items 501–600 of 1,001

The Potential Role of Fecal Microbiota Transplant in the Reversal or Stabilization of Multiple Sclerosis Symptoms: A Literature Review on Efficacy and Safety
Laeeq, T., Vongsavath, T., Tun, K. M., & Hong, A. S. (2023) · Microorganisms · doi:10.3390/microorganisms11122840 · Cited by 15
Implication of Oxysterols and Phytosterols in Aging and Human Diseases
Vigne, S., & Pot, C. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-43883-7_12 · Cited by 16
Viral DNAemia and DNA Virus Seropositivity and Mortality in Pediatric Sepsis
Cabler, S. S., Storch, G. A., Weinberg, J. B., Walton, A. H., Brengel‐Pesce, K., Aldewereld, Z., Banks, R., Cheynet, V., Reeder, R., Holubkov, R., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.0383 · Cited by 15
Inflammatory bowel disease is associated with an increase in the incidence of multiple sclerosis: a retrospective cohort study of 24,934 patients
Yaqubi, K., Kostev, K., Klein, I., Schüßler, S., May, P., Luedde, T., Roderburg, C., & Loosen, S. H. (2024) · European journal of medical research · doi:10.1186/s40001-024-01776-w · Cited by 16
“In MS, the risk of disease initiation was significantly increased after infection with EBV, but not other similarly transmitted viruses such as cytomegalovirus [33].”
Background
Challenges in Diagnosis and Therapeutic Strategies in Late-Onset Multiple Sclerosis
Nociti, V., Romozzi, M., & Massimiliano Mirabella, A. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14040400 · Cited by 17
“Besides genetic susceptibility, several environmental risk factors have been associated with an increased risk of MS, such as Epstein–Barr virus infection, smoking, obesity during adolescence, and vitamin D deficiency [12,13].”
Background
Amniotic fluid stem cell‐derived extracellular vesicles educate type 2 conventional dendritic cells to rescue autoimmune disorders in a multiple sclerosis mouse model
Manni, G., Gargaro, M., Ricciuti, D., Fontana, S., Padiglioni, E., Cipolloni, M., Mazza, T., Rosati, J. D., Veroli, A. D., Mencarelli, G., et al. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12446 · Cited by 15
“The interplay of complex genetic and environmental factors influences multiple sclerosis susceptibility (Bjornevik et al., 2022).”
Background
Endogenous retroviruses in multiple sclerosis: A network-based etiopathogenic model
Censi, S. T., Mariani‐Costantini, R., Granzotto, A., Tomassini, V., & Sensi, S. L. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102392 · Cited by 16
A gH/gL-encoding replicon vaccine elicits neutralizing antibodies that protect humanized mice against EBV challenge
Edwards, K. R., Malhi, H., Schmidt, K., Davis, A. R., Homad, L. J., Warner, N. L., Chhan, C. B., Scharffenberger, S. C., Gaffney, K., Hinkley, T. C., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00907-y · Cited by 15
Repurposing Licensed Drugs with Activity Against Epstein–Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach
Li, V., McKay, F. C., Tscharke, D. C., Smith, C., Khanna, R., Lechner‐Scott, J., Rawlinson, W. D., Lloyd, A. R., Taylor, B. V., Morahan, J. M., et al. (2025) · CNS Drugs · doi:10.1007/s40263-024-01153-5 · Cited by 15
“A recent study of US military personnel confirmed the strong Extended author information available on the last page of the article association between EBV and MS and provided arguments that the association is causal [9].”
Haplotype analysis reveals pleiotropic disease associations in the HLA region
Smith, C. J., Strausz, S. J., FinnGen, Spence, J. P., Ollila, H. M., & Pritchard, J. K. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.06.011 · Cited by 17
Association of Cytomegalovirus Serostatus With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responsiveness in Nursing Home Residents and Healthcare Workers
Freeman, M. L., Oyebanji, O. A., Moisi, D. D., Payne, M., Sheehan, M. L., Balazs, A. B., Bosch, J., King, C. L., Gravenstein, S., Lederman, M. M., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad063 · Cited by 18
Aging and infectious diseases in myasthenia gravis
Bril, V., & Gilhus, N. E. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123314 · Cited by 15
Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis
Comabella, M., Hegen, H., Villar, L. M., Rejdak, K., Sao‐Avilés, A., Behrens, M., Sastre‐Garriga, J., Mongay‐Ochoa, N., Berek, K., Martínez‐Yélamos, S., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12763-w · Cited by 14
Epstein-Barr virus infection promotes T cell dysregulation in a humanized mouse model of multiple sclerosis
Allanach, J. R., Fettig, N. M., Hardman, B. K., Rosen, A. R., Fan, V., Chung, C., Goldberg, E. J., Morse, Z. J., Shanina, I., Vorobeychik, G., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu5110 · Cited by 14
Large-scale proteomics across neurological disorders uncovers biomarker panel and targets in multiple sclerosis
Bader, J. M., Makarov, C., Richter, S., Strauss, M. T., Held, F., Wahle, M., Lorenz, M., Pöschl, L., Skowronek, P., Thielert, M., et al. (2026) · Cell · doi:10.1016/j.cell.2026.01.017 · Cited by 15
Sex differences in immune responses to viruses, bacteria and vaccines
Chaulagain, S., Liu, J., McCombs, J. E., & Klein, S. L. (2026) · Nature Immunology · doi:10.1038/s41590-026-02470-1 · Cited by 16
Immune Privilege Furnishes a Niche for Latent Infection
Forrester, J. V., Mölzer, C., & Kuffová, L. (2022) · Frontiers in Ophthalmology · doi:10.3389/fopht.2022.869046 · Cited by 14
Therapeutic Role of Vitamin D in Multiple Sclerosis: An Essentially Contested Concept
Fatima, M., Lamis, A., Siddiqui, S. W., Ashok, T., Patni, N., & Fadiora, O. E. (2022) · Cureus · doi:10.7759/cureus.26186 · Cited by 14
Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis
Horjus, J., van Mourik-Banda, T., Heerings, M. A. P., Hakobjan, M., Witte, W. D., Heersema, D. J., Jansen, A. J., Strijbis, E. M. M., de Jong, B. A., Slettenaar, A. E. J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911461 · Cited by 15
Better late than never: A unique strategy for late gene transcription in the beta- and gammaherpesviruses
Dremel, S. E., & Didychuk, A. L. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.12.001 · Cited by 14
Do magnetic resonance imaging features differ between persons with multiple sclerosis of various races and ethnicities?
Nathoo, N., Zeydan, B., Neyal, N., Chelf, C. J., Okuda, D. T., & Kantarci, O. H. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1215774 · Cited by 16
Epstein–Barr virus and genetic risk variants as determinants of T-bet+ B cell-driven autoimmune diseases
Bogers, L., Kuiper, K. L., Smolders, J., Rip, J., & van Luijn, M. M. (2023) · Immunology Letters · doi:10.1016/j.imlet.2023.07.006 · Cited by 14
Patients with psychosis spectrum disorders hospitalized during the COVID-19 pandemic unravel overlooked SARS-CoV-2 past infection clustering with HERV-W ENV expression and chronic inflammation
Tamouza, R., Meyer, U., Lucas, A., Richard, J., Nkam, I., Pinot, A., Djonouma, N., Boukouaci, W., Charvet, B., Pierquin, J., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02575-3 · Cited by 14
Ancient DNA reveals evolutionary origins of autoimmune diseases
Barrie, W., Irving-Pease, E. K., Willerslev, E., Iversen, A. K. N., & Fugger, L. H. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-023-00983-6 · Cited by 13
Antiviral therapy with tenofovir in MS
Torkildsen, Ø., Myhr, K., Brugger‐Synnes, P., & Bjørnevik, K. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105436 · Cited by 14
Coeliac disease: the paradox of diagnosing a food hypersensitivity disorder with autoantibodies
du Pré, M. F., Iversen, R., & Sollid, L. M. (2024) · Gut · doi:10.1136/gutjnl-2023-331595 · Cited by 14
Altered EBV specific immune control in multiple sclerosis
Münz, C. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578343 · Cited by 16
Safety and Dose-Response of Vidofludimus Calcium in Relapsing Multiple Sclerosis
Fox, R. J., Wiendl, H., Wolf, C., Stefano, N. D., Sellner, J., Gryb, V. A., Rejdak, K., Bozhinov, P. S., Vitt, D., Kohlhof, H., et al. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200208 · Cited by 16
Auto-immuno-deficiency syndromes
Houen, G. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103610 · Cited by 14
Clinical correlates of lifetime and current comorbidity patterns in autoimmune and inflammatory diseases
Hässler, S., Lorenzon, R., Binvignat, M., Ribet, C., Roux, A., Johanet, C., Amouyal, C., Amselem, S., Berenbaum, F., Benvéniste, O., et al. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103318 · Cited by 14
Transactivation of Human Endogenous Retroviruses by Viruses
Evans, E., Saraph, A., & Tokuyama, M. (2024) · Viruses · doi:10.3390/v16111649 · Cited by 15
Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans
Harley, I. T. W., Allison, K., & Scofield, R. H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.953439 · Cited by 15
The Association between Infectious Mononucleosis and Cancer: A Cohort Study of 24,190 Outpatients in Germany
Roderburg, C., Krieg, S., Krieg, A. H., Luedde, T., Kostev, K., & Loosen, S. H. (2022) · Cancers · doi:10.3390/cancers14235837 · Cited by 14
Recent Progress in Multiple Sclerosis Treatment Using Immune Cells as Targets
Ma, X., Ma, R., Zhang, M., Qian, B., Wang, B. B., & Yang, W. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030728 · Cited by 17
Out-of-Africa migration and clonal expansion of a recombinant Epstein-Barr virus drives frequent nasopharyngeal carcinoma in southern China
Zhang, X., Chen, Y., Liang, J., Yang, Y., Chen, H., Chen, Z., Li, M., Chen, S., Chen, T., He, H., et al. (2024) · National Science Review · doi:10.1093/nsr/nwae438 · Cited by 13
“…after primary infection, EBV has been linked to a wide spectrum of malignancies, including endemic Burkitt’s lymphoma (BL), Hodgkin lymphoma (HL), NK/T cell lymphomas, a subtype of gastric cancer (GC), nasopharyngeal cancer (NPC) [1 ] as well as recently reported multiple sclerosis (MS) [2 ,3 ].”
Core features and inherent diversity of post-acute infection syndromes
Trautmann, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1509131 · Cited by 13
“Most autoimmune diseases (113 – 115), as well as PAIS, appear after infections from which a majority of people recover without sequaele.”
Disease–disease interactions: molecular links of neurodegenerative diseases with cancer, viral infections, and type 2 diabetes
Lin, Y., Yoo, J. M., Li, D., Heo, Y., Okumura, M., Won, H., Vendruscolo, M., Lim, M. H., & Lee, Y. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00507-3 · Cited by 16
“In addition to its potential involvement in AD, mounting evidence suggests that EBV infection may target B cells and contribute to the onset of multiple sclerosis (MS) [139, 140].”
Lysine-specific histone demethylase complex restricts Epstein–Barr virus lytic reactivation
Liao, Y., Yan, J., Kong, I. Y., Li, Z., Ding, W., Clark, S. E., Maestri, D., Yoshida, T., Giulino-Roth, L. G., & Gewurz, B. E. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02165-7 · Cited by 13
The lingering shadow of epidemics: post-acute sequelae across history
Miller, C. M., Moen, J. K., & Iwasaki, A. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.10.010 · Cited by 13
Virus-specific antibody indices may supplement the total IgG index in diagnostics of multiple sclerosis
Kyllesbech, C., Trier, N. H., Slibinskas, R., Čiplys, E., Tsakiri, A., Frederiksen, J. L., & Houen, G. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577868 · Cited by 13
Association Between Cytomegalovirus Infection and Tuberculosis Disease: A Systematic Review and Meta-Analysis of Epidemiological Studies
Kua, K. P., Chongmelaxme, B., & Lee, S. W. H. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac179 · Cited by 13
Neurology of Acute Viral Infections
Krett, J. D., Beckham, J. D., Tyler, K. L., Piquet, A. L., Chauhan, L., Wallace, C. J., Pastula, D. M., & Kapadia, R. K. (2022) · The Neurohospitalist · doi:10.1177/19418744221104778 · Cited by 13
G 1 /S Cell Cycle Induction by Epstein-Barr Virus BORF2 Is Mediated by P53 and APOBEC3B
Yockteng-Melgar, J., Shire, K., Cheng, A. Z., Malik-Soni, N., Harris, R. S., & Frappier, L. (2022) · Journal of Virology · doi:10.1128/jvi.00660-22 · Cited by 14
Infectious mononucleosis is associated with an increased incidence of Crohn’s disease: results from a cohort study of 31 862 outpatients in Germany
Loosen, S. H., Kostev, K., Schöler, D., Orth, H.-M., Freise, N. F., Jensen, B. O., May, P., Bode, J. G., Roderburg, C., & Luedde, T. (2023) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002505 · Cited by 13
Chronic Epstein-Barr virus infection: A potential junction between primary Sjögren’s syndrome and lymphoma
Yang, L., Pu, J., Cai, F., Zhang, Y., Gao, R., Zhuang, S., Liang, Y., Wu, Z., Pan, S., Song, J., et al. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156227 · Cited by 13
Regulation of EBNA1 protein stability and DNA replication activity by PLOD1 lysine hydroxylase
Dheekollu, J., Wiedmer, A., Soldan, S. S., Castro-Muñoz, L. J., Chen, C., Tang, H., Speicher, D. W., & Lieberman, P. M. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1010478 · Cited by 13
Platelets are a major player and represent a therapeutic opportunity in systemic lupus erythematosus
Robert, M., & Scherlinger, M. (2023) · Joint Bone Spine · doi:10.1016/j.jbspin.2023.105622 · Cited by 13
Transcriptome alterations in peripheral blood B cells of patients with multiple sclerosis receiving immune reconstitution therapy
Hecker, M., Fitzner, B., Boxberger, N., Putscher, E., Engelmann, R., Bergmann, W., Müller, M. K., Ludwig‐Portugall, I., Schwartz, M., Meister, S., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02859-x · Cited by 13
Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation
Zettl, U. K., Rommer, P. S., Aktaş, O., Wagner, T. B., Richter, J., Oschmann, P., Cepek, L., Elias-Hamp, B., Gehring, K., Chan, A., et al. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2248391 · Cited by 18
Relevance of tissue-resident memory CD8 T cells in the onset of Parkinson’s disease and examination of its possible etiologies: infectious or autoimmune?
de Fàbregues, O., Sellés, M. C., Ramos-Vicente, D., Roch, G., Vila, M., & Bové, J. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106308 · Cited by 12
Association Between Diseases and Symptoms Diagnosed in Primary Care and the Subsequent Specific Risk of Multiple Sclerosis
Guinebretiere, O., Nédelec, T., Gantzer, L., Lekens, B., Durrleman, S., & Louapre, C. (2023) · Neurology · doi:10.1212/wnl.0000000000207981 · Cited by 15
Peripheral memory B cells in multiple sclerosis vs. double negative B cells in neuromyelitis optica spectrum disorder: disease driving B cell subsets during CNS inflammation
Tieck, M. P., Vasilenko, N., Ruschil, C., & Kowarik, M. C. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1337339 · Cited by 14
The Impact of Cytomegalovirus Infection on Natural Killer and CD8+ T Cell Phenotype in Multiple Sclerosis
Perri, V., Zingaropoli, M. A., Pasculli, P., Ciccone, F., Tartaglia, M., Baione, V., Malimpensa, L., Ferrazzano, G., Mastroianni, C. M., Conte, A., et al. (2024) · Biology · doi:10.3390/biology13030154 · Cited by 13
“The Epstein–Barr virus (EBV) appears to play a major role in MS; however, many studies have also focused on the putative involvement of cytomegalovirus (CMV) [6,7].”
Background
Applying a genetic risk score model to enhance prediction of future multiple sclerosis diagnosis at first presentation with optic neuritis
Loginovic, P., Wang, F., Li, J., Ferrat, L. A., Mirshahi, U. L., Rao, H. S., Petzold, A., Tyrrell, J., Green, H., Weedon, M. N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44917-9 · Cited by 17
“Additionalrisk factors for MS include female sex, age at onset 21 , latitude of country of residence, low serum 25-hydroxyvitamin 22 – 24 , increased body mass index 22,24 – 26 , Epstein-Barr virus seropositivity 27 , and smoking 28,29 30 .”
Infectious mononucleosis: new concepts in clinical presentation, epidemiology, and host response
Naughton, P., Enright, F., & Lucey, B. (2024) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000001012 · Cited by 13
Epstein-Barr Virus in the Cerebrospinal Fluid and Blood Compartments of Patients With Multiple Sclerosis and Controls
Lehikoinen, J., Nurmi, K., Ainola, M., Clancy, J., Nieminen, J. K., Jansson, L., Vauhkonen, H., Vaheri, A. I., Smura, T., Laakso, S. M., et al. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200226 · Cited by 13
Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus
Edwards, K. R., Schmidt, K., Homad, L. J., Kher, G. M., Xu, G., Rodrigues, K. A., Ben‐Akiva, E., Abbott, J., Prlic, M., Newell, E. W., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101587 · Cited by 13
MicroRNA-focused CRISPR/Cas9 screen identifies miR-142 as a key regulator of Epstein-Barr virus reactivation
Chen, Y., Kincaid, R. P., Bastin, K., Fachko, D. N., & Skalsky, R. L. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011970 · Cited by 13
Integrating genetic and proteomic data to elucidate the association between immune system and blood-brain barrier dysfunction with multiple sclerosis risk and severity
Sun, D., Wang, R., Du, Q., Chen, H., Shi, Z., Zhang, Y., Zhang, N., Wang, X., & Zhou, H. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.07.135 · Cited by 12
New views on the complex interplay between degeneration and autoimmunity in multiple sclerosis
Stys, P. K., Tsutsui, S., Gafson, A., Hart, B. A. ‘., Belachew, S. M., & Geurts, J. J. G. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1426231 · Cited by 14
Understanding the Cytomegalovirus Cyclin-Dependent Kinase Ortholog pUL97 as a Multifaceted Regulator and an Antiviral Drug Target
Marschall, M., Schütz, M., Wild, M. R., Socher, E., Wangen, C., Dhotre, K., Rawlinson, W. D., & Sticht, H. (2024) · Cells · doi:10.3390/cells13161338 · Cited by 13
“Recently the evidence for EBV association with multiple sclerosis (MS) provides the opportunity for trials of novel MS therapies, including EBV vaccination and antiherpesviral drugs, to reduce the effect of this cofactor [7–9].”
Background
Epstein-Barr virus induces host shutoff extensively via BGLF5-independent mechanisms
Casco, A., Ohashi, M., & Johannsen, E. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114743 · Cited by 13
Microglial Mayhem NLRP3 Inflammasome's Role in Multiple Sclerosis Pathology
Fan, H., Fu, Q., Du, G., Ling, Q., Shi, X., Wang, D., & Yang, Y. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70135 · Cited by 13
Multiple Sclerosis: Glial Cell Diversity in Time and Space
Kooistra, S. M., & Schirmer, L. (2024) · Glia · doi:10.1002/glia.24655 · Cited by 14
The epidemiology, pathology and pathogenesis of MS: Therapeutic implications
Goodin, D. S. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00539 · Cited by 16
“It is an extremely common human infection with more than 90 % of the population ultimately becoming infected with EBV by the time they reach adulthood [116 – 129] – see also Table 8.”
Multiple sclerosis: an immune attack on astrocyte-mediated ion and water homeostasis
van der Knaap, M. S., & Min, R. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01081-y · Cited by 14
T cell receptor clonotypes predict human leukocyte antigen allele carriage and antigen exposure history
ElAbd, H., Mahdy, A. K. H., Wacker, E. M., Gretsova, M., Ellinghaus, D., Dempfle, A., & Franke, A. (2026) · Communications Biology · doi:10.1038/s42003-025-09140-2 · Cited by 13
“…example,inappropriateimmuneresponsestowardEpstein-Barrvirushave beenassociatedwithmultipleautoimmuneandchronicin ﬂ ammatory diseases such as multiple sclerosis 41 , rheumatoid arthritis 42 , Sjögren syndrome 43 , and primary sclerosing cholangitis 19 .”
Changes in Brain Neuroimmunology Following Injury and Disease
Tabet, A., Apra, C., Stranahan, A. M., & Anikeeva, P. (2022) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2022.894500 · Cited by 15
Multiple sclerosis and the microbiota
Engelenburg, H. J., Lucassen, P. J., Sarafian, J. T., Parker, W., & Laman, J. D. (2022) · Evolution Medicine and Public Health · doi:10.1093/emph/eoac009 · Cited by 13
Peptide Microarrays for Studying Autoantibodies in Neurological Disease
Talucci, I., & Maric, H. M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2732-7_2 · Cited by 14
Transcriptional abnormalities in induced pluripotent stem cell-derived oligodendrocytes of individuals with primary progressive multiple sclerosis
Plastini, M. J., Desu, H. L., Ascona, M. C., Lang, A. L., Saporta, M., & Brambilla, R. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.972144 · Cited by 12
MicroRNAs as a possible biomarker in the treatment of multiple sclerosis
Gallardo‐Pérez, M. M., & Garcés‐Eisele, S. J. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.11.001 · Cited by 13
Antiviral Innate Immune Responses in Autoimmunity: Receptors, Pathways, and Therapeutic Targeting
Stergioti, E. M., Manolakou, T., Boumpas, D. T., & Banos, A. (2022) · Biomedicines · doi:10.3390/biomedicines10112820 · Cited by 15
Causal associations between prodromal infection and neuromyelitis optica spectrum disorder: A Mendelian randomization study
Wang, L., Zhou, L., ZhangBao, J., Huang, W., Tan, H., Fan, Y., Lü, C., Yu, J. Y., Wang, M., Lu, J., et al. (2023) · European Journal of Neurology · doi:10.1111/ene.16014 · Cited by 14
Risk of Multiple Sclerosis in People Living with HIV : An International Cohort Study
McKay, K. A., Wijnands, J. M. A., Manouchehrinia, A., Zhu, F., Sereda, P., Li, J., Ye, M., Trigg, J., Kooij, K. W., Ekström, A. M., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26840 · Cited by 13
Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment
Berg, L. P., Eriksson, M., Longhi, S., Kockum, I. S., Warnke, C., Thomsson, E., Bäckström, M., Olsson, T. P., Fogdell‐Hahn, A., & Bergström, T. B. (2022) · BMJ Neurology Open · doi:10.1136/bmjno-2022-000271 · Cited by 12
The Role of Epstein-Barr Virus in the Pathogenesis of Autoimmune Diseases
Morawiec, N., Adamczyk, B., Spyra, A., Herba, M., Boczek, S., Korbel, N., Polechoński, P., & Adamczyk-Sowa, M. H. (2025) · Medicina · doi:10.3390/medicina61071148 · Cited by 12
“EBV infection preceded both the onset of symptoms and the first detectable pathological changes, suggesting that EBV is a major cause of MS (Table 2) [84].”
SARS-CoV-2 Spike Protein and Molecular Mimicry: An Immunoinformatic Screen for Cross-Reactive Autoantigen Candidates
Timofeeva, A. M., Aulova, K. S., Mustaev, E. A., & Nevinsky, G. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188793 · Cited by 15
“For example, infection with the Epstein–Barr virus has been linked to an over-30-fold increased risk of multiple sclerosis [9–12].”
Risk HLA Variants Affect the T-Cell Repertoire in Multiple Sclerosis
Sorosina, M., Santoro, S., Ferrè, L., Mascia, E., Clarelli, F., Giordano, A., Cannizzaro, M., Moiola, L., Martinelli, V., Filippi, M., et al. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200093 · Cited by 13
The Role of MRI in Differentiating Demyelinating and Inflammatory (not Infectious) Myelopathies
Tamanini, J. V. G., Sabino, J. V., Cordeiro, R. A., Mizubuti, V., Villarinho, L. D. L., Duarte, J. Á., Pereira, F. V., Appenzeller, S., Damasceno, A., & Reis, F. (2023) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2023.03.017 · Cited by 14
Systemic immune derangements are shared across various CNS pathologies and reflect novel mechanisms of immune privilege
Lorrey, S., Polania, J. W., Wachsmuth, L. P., Hoyt-Miggelbrink, A. M., Tritz, Z. P., Edwards, R. M., Wolf, D. M., Johnson, A. J., Fecci, P. E., & Ayasoufi, K. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad035 · Cited by 14
Adult‐onset depletion of sulfatide leads to axonal degeneration with relative myelin sparing
Dustin, E., McQuiston, A. R., Honke, K., Palavicini, J. P., Han, X., & Dupree, J. L. (2023) · Glia · doi:10.1002/glia.24423 · Cited by 11
Alzheimer’s disease and multiple sclerosis: a possible connection through the viral demyelinating neurodegenerative trigger (vDENT)
Boukhvalova, M. S., Kastrukoff, L. F., & Blanco, J. C. G. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1204852 · Cited by 11
Could Mathematics be the Key to Unlocking the Mysteries of Multiple Sclerosis?
Weatherley, G. R., Araujo, R. P., Dando, S. J., & Jenner, A. L. (2023) · Bulletin of Mathematical Biology · doi:10.1007/s11538-023-01181-0 · Cited by 13
The role of diet in multiple sclerosis onset and course: results from a nationwide retrospective birth‐year cohort
Loonstra, F. C., de Ruiter, L. R. J., Schoonheim, M. M., Moraal, B., Strijbis, E. M. M., de Jong, B. A., & Uitdehaag, B. M. J. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51788 · Cited by 13
The Potential Role of SARS-CoV-2 Infection and Vaccines in Multiple Sclerosis Onset and Reactivation: A Case Series and Literature Review
Tavazzi, E., Pichiecchio, A., Colombo, E., Rigoni, E., Asteggiano, C., Vegezzi, E., Masi, F., Greco, G., Bastianello, S., & Bergamaschi, R. (2023) · Viruses · doi:10.3390/v15071569 · Cited by 12
Application of mNGS in the study of pulmonary microbiome in pneumoconiosis complicated with pulmonary infection patients and exploration of potential biomarkers
Yuan, X., Xie, L., Shi, Z., & Zhou, M. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1200157 · Cited by 12
Diversification and expansion of the EBV-reactive cytotoxic T lymphocyte repertoire following autologous haematopoietic stem cell transplant for multiple sclerosis
Massey, J. C., Artuz, C. M., Dyer, Z., Jackson, K., Khoo, M., Visweswaran, M., Withers, B., Moore, J. J., Ma, D. D. F., & Sutton, I. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109709 · Cited by 12
Modulation of Epstein-Barr-Virus (EBV)-Associated Cancers by Co-Infections
Münz, C. (2023) · Cancers · doi:10.3390/cancers15245739 · Cited by 12
Autoimmune demyelination alters hypothalamic transcriptome and endocrine function
Carver, J. J., Lau, K. M., Puckett, A. E., & Didonna, A. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-03006-2 · Cited by 13
“In this light, it is intriguing that Epstein–Barr virus (EBV) infection has been recently characterized as the main environmental factor for MS susceptibility [36].”
Background
Adverse Childhood Experiences and the Risk of Multiple Sclerosis Development: A Review of Potential Mechanisms
Eid, K., Bjørk, M., Gilhus, N. E., & Torkildsen, Ø. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031520 · Cited by 14
“Epstein-Barr Virus (EBV) infection is hypothesized to be a causal risk factor for MS and is associated with a 32-fold increase in MS risk [1].”
Background
Multiscale networks in multiple sclerosis
Kennedy, K., de Rosbo, N. K., Uccelli, A., Cellerino, M., Ivaldi, F., Contini, P., Palma, R. D., Harbo, H. F., Berge, T., Bos, S. D., et al. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010980 · Cited by 12
Rapamycin rescues loss of function in blood-brain barrier–interacting Tregs
Baeten, P., Hamad, I., Hoeks, C., Hiltensperger, M., Wijmeersch, B. V., Popescu, V., Aly, L., Somers, V. A., Korn, T., Kleinewietfeld, M., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.167457 · Cited by 12
Epstein‐Barr virus‐driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinoma
Shi, F., Li, S., Zhou, M., Lv, C., Li, Y., Luo, C., Liu, N., Lu, J., Tang, M., Luo, X., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29634 · Cited by 12
A parasite odyssey: An RNA virus concealed in Toxoplasma gondii
Gupta, P., Hiller, A., Chowdhury, J., Lim, D., Lim, D. Y., Saeij, J. P. J., Babaian, A., Rodriguez, F., Pereira, L., & Morales-Tapia, A. (2024) · Virus Evolution · doi:10.1093/ve/veae040 · Cited by 12
“The EBV-MS association has long been statistically postulated, yet clear evidence for causality was only established recently, on a background of increasing awareness of the role of neuroinflammation in neurodegeneration (Bjornevik et al. 2022; Lanz et al. 2022; Soldan and Lieberman 2023).”
Background
Multiple Sclerosis: Immune Cells, Histopathology, and Therapeutics
Patil, M. S., Lin, L. Y., Marsh‐Wakefield, F., James, E. J., Palendira, M., Hawke, S. H., & Grau, G. E. (2024) · Sclerosis · doi:10.3390/sclerosis2030009 · Cited by 15
Effect on neutrophil migration and antimicrobial functions by the Bruton's tyrosine kinase inhibitors tolebrutinib, evobrutinib, and fenebrutinib
Bondt, M. D., Renders, J., de Prado, P. P., Berghmans, N., Pörtner, N., Vanbrabant, L., de Oliveira, V. L. S., Duran, G., Baeten, P., Broux, B., et al. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae160 · Cited by 15
Microglia as potential key regulators in viral-induced neuroinflammation
Ismail, F. S., Faustmann, T. J., Faustmann, P. M., & Corvace, F. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1426079 · Cited by 13
The refined Pathways to Cures Research Roadmap for multiple sclerosis cures
Bebo, B. F., Banwell, B., Whitacre, C. C., Coetzee, T., Dalgas, U., Jager, P. L. D., Pröbstel, A., Yong, V. W., Benveniste, E. N., & Thompson, A. J. (2024) · Multiple Sclerosis Journal · doi:10.1177/13524585241266483 · Cited by 12
Cytomegalovirus immune responses are associated with lower serum NfL and disability accumulation risk at multiple sclerosis onset
Lünemann, J. D., Sao‐Avilés, A., Tintoré, M., Midaglia, L. S., Fissolo, N., Gutiérrez, L., Wiendl, H., Montalbán, X., & Comabella, M. (2024) · Multiple Sclerosis Journal · doi:10.1177/13524585241274571 · Cited by 12

Authors: Bjornevik, K., Cortese, M., Healy, B. C., Kuhle, J., Mina, M. J., Leng, Y., Elledge, S. J., Niebuhr, D. W., Scher, A. I., Munger, K. L., & Ascherio, A.
Affiliations: Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Harvard University (US)
Brigham and Women's Hospital (US)
Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.
Uniformed Services University of the Health Sciences (US)
Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Corresponding author: Cortese, Marianna
Munger, Kassandra L.
Ascherio, Alberto
ORCID: Bjornevik, Kjetil
Cortese, Marianna
Healy, Brian C.
Mina, Michael J.
Leng, Yumei
Elledge, Stephen J.
Munger, Kassandra L.
Ascherio, Alberto
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2022-01-21
Volume: 375
Issue: 6578
Pages: 296-301
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.abj8222
OpenAlex: W4205972999
Cited by: 2,049
References: 51
Citations by year: 2026: 354 · 2025: 412 · 2024: 461 · 2023: 432 · 2022: 388
FWCI: 289.56
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: Howard Hughes Medical Institute
National Institute of Neurological Disorders and Stroke (R01NS042194, R01NS046635, R01NS103891)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
Keywords: multiple sclerosis, Epstein-Barr virus, viral etiology, neurofilament light chain, neuroaxonal degeneration, cytomegalovirus, demyelinating disease, military personnel
MeSH terms: Antibodies, Viral, Cytomegalovirus, Herpesvirus 4, Human, Female, Humans, Longitudinal Studies, Male, Military Personnel, Multiple Sclerosis, Risk Factors, Cohort Studies, Biomarkers, Prevalence, Neurofilament Proteins, Age of Onset, Epstein-Barr Virus Infections, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks